SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (732)9/9/1999 11:50:00 PM
From: GemSeeker  Read Replies (1) of 849
 
This story, if accurate, should garner ENORMOUS publicity in the next couple of weeks. Breast cancer is the favorite media health story these days. If NMPS has the goods, buyers will be standing in line outside their door, just off the publicity alone. Absolutely no comparison between this product and anything else Matritech has ever done. Bladder cancer test annual revenues will be less than one days revenue for this product if and when it goes into production. They won't need a sales staff if this thing works, just an enormous production facility and plenty of order takers!

I don't know what kind of gap up to expect, but my guess is that whatever it opens at tomorrow, it will continue to climb steadily over the next few weeks as this story builds momentum in the media.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News